Surveillance of the impact of pneumococcal conjugate vaccines in developing countries.
Hum Vaccin Immunother
; 12(2): 417-20, 2016.
Article
em En
| MEDLINE
| ID: mdl-26309055
ABSTRACT
Infection due to Streptococcus pneumoniae is a leading cause of morbidity and mortality in young children, especially in developing countries. With the support of Gavi, the Vaccine Alliance, the majority of these countries have introduced pneumococcal conjugate vaccines (PCV) into their national immunization programs and early data demonstrate a high degree of effectiveness, translating to enormous public health benefit through both direct and indirect (herd) effects. Future vaccination strategy may be focused on maintaining herd effects rather than individual protection. Evaluation of vaccine-type carriage, particularly in pneumonia cases, may be an easy, feasible way of measuring continued vaccine impact.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Pneumocócica
/
Portador Sadio
/
Vacinação
/
Vacinas Conjugadas
/
Programas de Imunização
/
Vacinas Pneumocócicas
Tipo de estudo:
Screening_studies
Limite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article